Your browser doesn't support javascript.
loading
Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study.
Younis, Brima Musa; Mudawi Musa, Ahmed; Monnerat, Séverine; Abdelrahim Saeed, Mohammed; Awad Gasim Khalil, Eltahir; Elbashir Ahmed, Anas; Ahmed Ali, Mujahid; Noureldin, Ali; Muthoni Ouattara, Gina; Nyakaya, Godfrey M; Teshome, Samuel; Omollo, Truphosa; Ochieng, Michael; Egondi, Thaddaeus; Mmbone, Mildred; Chu, Wan-Yu; Dorlo, Thomas P C; Zijlstra, Eduard E; Wasunna, Monique; Alvar, Jorge; Alves, Fabiana.
Afiliación
  • Younis BM; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Mudawi Musa A; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Monnerat S; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Abdelrahim Saeed M; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Awad Gasim Khalil E; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Elbashir Ahmed A; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Ahmed Ali M; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Noureldin A; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Muthoni Ouattara G; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Nyakaya GM; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Teshome S; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Omollo T; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Ochieng M; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Egondi T; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Mmbone M; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Chu WY; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Dorlo TPC; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Zijlstra EE; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Wasunna M; Drugs for Neglected Diseases initiative, Nairobi, Kenya.
  • Alvar J; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Alves F; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
PLoS Negl Trop Dis ; 17(11): e0011780, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37988402
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leishmaniasis Cutánea / Leishmaniasis Visceral / Antiprotozoarios Límite: Child / Humans Idioma: En Revista: PLoS Negl Trop Dis Asunto de la revista: MEDICINA TROPICAL Año: 2023 Tipo del documento: Article País de afiliación: Sudán Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leishmaniasis Cutánea / Leishmaniasis Visceral / Antiprotozoarios Límite: Child / Humans Idioma: En Revista: PLoS Negl Trop Dis Asunto de la revista: MEDICINA TROPICAL Año: 2023 Tipo del documento: Article País de afiliación: Sudán Pais de publicación: Estados Unidos